Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Invested Capital (2016 - 2025)

Historic Invested Capital for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $4.4 million.

  • Biomerica's Invested Capital fell 1327.73% to $4.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $4.4 million, marking a year-over-year decrease of 1327.73%. This contributed to the annual value of $4.1 million for FY2025, which is 3771.81% down from last year.
  • According to the latest figures from Q4 2025, Biomerica's Invested Capital is $4.4 million, which was down 1327.73% from $5.2 million recorded in Q3 2025.
  • In the past 5 years, Biomerica's Invested Capital registered a high of $11.7 million during Q2 2023, and its lowest value of $4.1 million during Q2 2025.
  • Over the past 5 years, Biomerica's median Invested Capital value was $8.1 million (recorded in 2022), while the average stood at $7.7 million.
  • In the last 5 years, Biomerica's Invested Capital surged by 12644.23% in 2021 and then plummeted by 5035.29% in 2024.
  • Over the past 5 years, Biomerica's Invested Capital (Quarter) stood at $8.9 million in 2021, then dropped by 18.63% to $7.2 million in 2022, then grew by 29.55% to $9.4 million in 2023, then crashed by 45.5% to $5.1 million in 2024, then dropped by 13.28% to $4.4 million in 2025.
  • Its Invested Capital stands at $4.4 million for Q4 2025, versus $5.2 million for Q3 2025 and $4.1 million for Q2 2025.